Tilray Inc sell stratec
Summary
This prediction ended on 29.10.18 with a price of €80.47. The SELL prediction by stratec for Tilray Inc performed very well with a performance of -58.45%. stratec has 50% into this predictionTilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tilray Inc | -14.105% | -14.105% | -78.620% | - |
iShares Core DAX® | -5.630% | -5.765% | 8.425% | 8.571% |
iShares Nasdaq 100 | -8.559% | -13.005% | 17.297% | 28.853% |
iShares Nikkei 225® | -9.576% | -9.058% | 3.827% | 0.117% |
iShares S&P 500 | -6.631% | -7.103% | 17.407% | 31.169% |
Comments by stratec for this prediction
In the thread Tilray Inc diskutieren
stratec stimmt der Sell-Einschätzung von tamam zu
stratec stimmt am 20.09.2018 der Sell-Einschätzung von tamam, aber mit dem Kursziel 90$ zu.
Überschrift: The Tilray Bubble Is Bound To Burst